|
05/14/2008 07:50 PM
|
|
Bupa chief steps down after 12-year stint
|
When Val Gooding steps down as chief executive of Bupa at the company's annual meeting, it will mark the end of a 12-year association
|
|
05/15/2008 03:00 AM
|
|
Foundation status target missed
|
Health ministers have missed by a mile the goal that every NHS hospital should, by March this year, have had the opportunity to become a foundation trust, writes...
|
|
05/15/2008 03:00 AM
|
|
Patient surveys proposal wins warm reception
|
Proposals that the NHS should for the first time pay for quality - giving hospitals more if patients report a good outcome from treatment - were given a warm welcome...
|
|
05/15/2008 03:00 AM
|
|
Hayfever vaccine lift for Allergy
|
Shares in Allergy Therapeutics rose more than 20 per cent after it said it planned to file with European regulators early next year for an allergy vaccine following...
|
|
05/13/2008 10:07 PM
|
|
Warning over drug trial's effects on testing
|
A pioneering clinical trial launched this year by a US-backed research institute may fundamentally reshape relations between payers and the pharmaceutical industry, IMS Health, the healthcare consultancy, warned
|
|
05/12/2008 06:43 PM
|
|
Southern Cross Healthcare searches for acquisitions
|
The country's largest provider of healthcare for the elderly said it was keen to buy smaller care home competitors as it increased its acquisition facility from £60m to £108m
|
|
05/09/2008 08:20 PM
|
|
Sanofi hit by talk of Plavix generic
|
A version of the French pharmaceutical group's blockbuster blood-thinning treatment could be given the go-ahead, which would sharply cut its sales
|
|
05/09/2008 05:45 PM
|
|
Optos wins award as it catches Brussels' eye
|
Dunfermline-based eyecare company, Optos has been awarded a European Commission inventor of the year award for its scanning laser technology
|
|
05/09/2008 03:17 AM
|
|
Drug side-effects prompt tougher code
|
Promotional information on medicines produced by British companies must explicitly state that adverse events should be reported amid growing concern from regulators
|
|
05/07/2008 06:33 PM
|
|
Medicine looks back to its roots
|
The study and use of local plants and products over many generations ought to provide valuable clues for modern drug developers around the world
|
|
05/07/2008 04:44 AM
|
|
GSK issues bonds to fund share buy-back
|
The pharmaceutical group is poised to raise a record $9bn from new corporate bonds as part of plans to increase its gearing to finance an ambitious repurchase plan
|
|
05/06/2008 11:20 PM
|
|
Profits at Ireland's United Drug rise 15%
|
United Drug increases underlying first-half profits by 15 per cent in spite of government-imposed price cuts to off-patent drugs
|
|
05/06/2008 11:13 PM
|
|
China hits at Baxter in heparin probe
|
Chinese regulators accused US drug company Baxter of failing to co-operate in an investigation over deaths linked to impurities in blood thinner heparin
|
|
05/05/2008 05:52 PM
|
|
Wal-Mart unveils generic drug plan
|
Retailer to offer 30-day supplies of over-the-counter generic and branded drugs at its $4 discount price in bid to compete with mail-order drug services
|
|
05/05/2008 04:39 PM
|
|
E-therapeutics in consultancy move
|
E-therapeutics is launching a consultancy service to help pharmaceutical and biotechnology groups make their research more cost-effective
|
